triiodothyronine has been researched along with Cardiovascular Diseases in 81 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A direct association between low triiodothyronine (T3) syndrome and cardiovascular (CV) mortality has been reported in hemodialysis patients." | 7.81 | Low Triiodothyronine Syndrome and Long-Term Cardiovascular Outcome in Incident Peritoneal Dialysis Patients. ( Chang, TI; Kang, EW; Nam, JY; Shin, SK, 2015) |
| "To evaluate cardiovascular functionality in patients with thyroid cancer, we have performed echocardiography and ambulatory blood pressure monitoring in 19 women with differentiated thyroid carcinoma during thyroxine withdrawal, at three time points: the last day on TSH-suppressive thyroxine doses (subclinical or mild hyperthyroidism), 4-7 days after withdrawal (normal free thyroxine (FT4) and free triiodothyronine (FT3) levels), and before 131I whole body scanning (overt hypothyroidism)." | 7.72 | Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma. ( Barrios, V; Botella-Carretero, JI; Caballero, C; Escobar-Morreale, HF; García-Robles, R; Gómez-Bueno, M; Sancho, J, 2004) |
| "We found a higher plasma concentration of total homocysteine (tHcy), an independent risk factor for cardiovascular disease, in patients with hypothyroidism (mean, 16." | 7.70 | Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. ( Aakvaag, A; Aanderud, S; Ericsson, UB; Lien, EA; Nedrebø, BG; Nygård, O; Refsum, H; Ueland, PM, 1998) |
| "Magnesium sulfate (MgSO4) has anti-inflammatory actions." | 5.43 | Effect of magnesium sulfate and thyroxine on inflammatory markers in a rat model of hypothyroidism. ( Abbas, AM; Sakr, HF, 2016) |
| "Subclinical hypothyroidism (SH) is characterized by a mildly elevated concentration of thyroid stimulating hormone (TSH) despite free thyroxine (FT4) and triiodothyronine (FT3) levels within the reference range." | 4.93 | Nitric Oxide as a Marker for Levo-Thyroxine Therapy in Subclinical Hypothyroid Patients. ( Bajic, V; Gluvic, Z; Isenovic, ER; Obradovic, M; Panic, A; Sudar-Milovanovic, E; Trebaljevac, J; Zarkovic, M, 2016) |
| "Controversy remains as to the risk of cardiovascular disease (CVD) associated with subclinical hypothyroidism (SCH), defined as an increased serum thyrotropin (TSH) concentration with normal free thyroxine and triiodothyronine levels." | 4.84 | Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence? ( Duntas, LH; Wartofsky, L, 2007) |
| "Compared to patients only taking l-thyroxine, those using liothyronine had no increased risk of cardiovascular disease [hazard ratio (HR) 1·04; 95% CI 0·70-1·54], atrial fibrillation (HR 0·91: 0·47-1·75), or fractures (HR 0·79: 0·49-1·27) after adjusting for age." | 3.83 | Liothyronine use in a 17 year observational population-based study - the tears study. ( Donnelly, LA; Leese, GP; Soto-Pedre, E, 2016) |
| "A direct association between low triiodothyronine (T3) syndrome and cardiovascular (CV) mortality has been reported in hemodialysis patients." | 3.81 | Low Triiodothyronine Syndrome and Long-Term Cardiovascular Outcome in Incident Peritoneal Dialysis Patients. ( Chang, TI; Kang, EW; Nam, JY; Shin, SK, 2015) |
| " Heart failure represents an intriguing clinical situation in which triiodothyronine treatment might be beneficial." | 3.80 | Cardiovascular disease and thyroid function. ( Faber, J; Selmer, C, 2014) |
| "To evaluate cardiovascular functionality in patients with thyroid cancer, we have performed echocardiography and ambulatory blood pressure monitoring in 19 women with differentiated thyroid carcinoma during thyroxine withdrawal, at three time points: the last day on TSH-suppressive thyroxine doses (subclinical or mild hyperthyroidism), 4-7 days after withdrawal (normal free thyroxine (FT4) and free triiodothyronine (FT3) levels), and before 131I whole body scanning (overt hypothyroidism)." | 3.72 | Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma. ( Barrios, V; Botella-Carretero, JI; Caballero, C; Escobar-Morreale, HF; García-Robles, R; Gómez-Bueno, M; Sancho, J, 2004) |
| "We found a higher plasma concentration of total homocysteine (tHcy), an independent risk factor for cardiovascular disease, in patients with hypothyroidism (mean, 16." | 3.70 | Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. ( Aakvaag, A; Aanderud, S; Ericsson, UB; Lien, EA; Nedrebø, BG; Nygård, O; Refsum, H; Ueland, PM, 1998) |
| "In acute and subacute disease the active thyroid hormones, triiodothyronine (T3) and tetraiodothyroacetic acid (tetrac), are decreased while serum-thyroxine (T4) levels tend to be slightly reduced." | 3.65 | Reduced active thyroid hormone levels in acute illness. ( Braverman, L; Burger, A; Nicod, P; Suter, P; Vagenakis, P; Vallotton, MB, 1976) |
| "Hypothyroidism has been associated with atherosclerosis." | 2.71 | Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism. ( Cantürk, NZ; Cantürk, Z; Cetinarslan, B; Duman, C; Ozden, M; Tarkun, I, 2003) |
| " Today it still remains unclear whether the change in the bioavailability of thyroid hormones in the myocardium is a favorable physiological mechanism or a replication of an adaptation disorder." | 2.66 | [Use of thyroid hormones in the treatment of cardiovascular diseases: literature review]. ( Borisov, DV; Gubaeva, DN; Praskurnichiy, EA, 2020) |
| "triiodothyronine) have been associated with adverse cardiovascular sequelae in CKD and ESRD patients, but these metrics are confounded by malnutrition, inflammation and comorbid states, and hence may signify nonthyroidal illness (i." | 2.52 | Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients. ( Brent, GA; Brunelli, SM; Budoff, MJ; Kalantar-Zadeh, K; Kovesdy, CP; Nguyen, D; Rhee, CM; Soldin, OP, 2015) |
| "Subclinical hypothyroidism affects 4." | 1.56 | Subclinical hypothyroidism: To treat or not to treat? ( Allen, S; Simon, C; Weidman-Evans, E, 2020) |
| "Effectively treating metabolic syndrome and its progression to type 2 diabetes, steatohepatitis and cardiovascular disease remain a major clinical challenge." | 1.46 | Metabolic Syndrome: One Speckled Stone Kills a Flock of Birds? ( Angelin, B; Bonde, Y, 2017) |
| "Magnesium sulfate (MgSO4) has anti-inflammatory actions." | 1.43 | Effect of magnesium sulfate and thyroxine on inflammatory markers in a rat model of hypothyroidism. ( Abbas, AM; Sakr, HF, 2016) |
| "Thirty patients with untreated hyperthyroidism and 25 age- and sex-matched healthy controls were included in the study." | 1.35 | Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism. ( Erem, C; Ersoz, HO; Kocak, M; Nuhoglu, İ; Ucuncu, O; Yilmaz, M, 2009) |
| "The metabolic syndrome was defined according to National Cholesterol Education Program's Adult Treatment Panel III criteria." | 1.34 | Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. ( Bakker, SJ; Gans, RO; Links, TP; Roos, A; Wolffenbuttel, BH, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (14.81) | 18.7374 |
| 1990's | 3 (3.70) | 18.2507 |
| 2000's | 22 (27.16) | 29.6817 |
| 2010's | 32 (39.51) | 24.3611 |
| 2020's | 12 (14.81) | 2.80 |
| Authors | Studies |
|---|---|
| Post, A | 2 |
| Garcia, E | 1 |
| Gruppen, EG | 2 |
| Kremer, D | 1 |
| Connelly, MA | 1 |
| Bakker, SJL | 2 |
| Dullaart, RPF | 2 |
| Shan, SK | 1 |
| Yan, T | 1 |
| Yuan, LQ | 1 |
| Li, S | 1 |
| Zeng, M | 1 |
| Liu, C | 1 |
| Xin, Z | 1 |
| Hua, L | 1 |
| Suonsyrjä, N | 1 |
| Laihia, I | 1 |
| Huhtala, H | 1 |
| Jaatinen, P | 1 |
| Metso, S | 1 |
| Torre, F | 1 |
| Calogero, AE | 1 |
| Condorelli, RA | 1 |
| Cannarella, R | 1 |
| Aversa, A | 1 |
| La Vignera, S | 1 |
| Simon, C | 1 |
| Weidman-Evans, E | 1 |
| Allen, S | 1 |
| Groothof, D | 1 |
| Flores-Guerrero, JL | 1 |
| Nolte, IM | 1 |
| Bouma, HR | 1 |
| Bano, A | 1 |
| Kootstra-Ros, JE | 1 |
| Hak, E | 1 |
| Bos, JHJ | 1 |
| de Borst, MH | 1 |
| Gans, ROB | 1 |
| Links, TP | 2 |
| Khan, M | 1 |
| Mukherjee, S | 1 |
| Bank, S | 1 |
| Maiti, S | 1 |
| Borisov, DV | 1 |
| Gubaeva, DN | 1 |
| Praskurnichiy, EA | 1 |
| Yamazaki, Y | 1 |
| Shoji, T | 1 |
| Miyashima, M | 1 |
| Nagata, Y | 1 |
| Kakutani, Y | 1 |
| Ochi, A | 1 |
| Morioka, T | 1 |
| Nakatani, S | 1 |
| Mori, K | 1 |
| Tsujimoto, Y | 1 |
| Emoto, M | 1 |
| Yuan, D | 1 |
| Jia, S | 1 |
| Zhu, P | 1 |
| Zhang, C | 1 |
| Liu, Y | 4 |
| Liu, R | 1 |
| Xu, J | 2 |
| Tang, X | 1 |
| Zhao, X | 1 |
| Gao, R | 1 |
| Yang, Y | 1 |
| Xu, B | 1 |
| Gao, Z | 1 |
| Yuan, J | 1 |
| Gao, J | 1 |
| Xu, Y | 1 |
| Kong, D | 1 |
| Zhou, L | 1 |
| Jia, H | 1 |
| Liang, B | 1 |
| Gu, Z | 1 |
| Goharbari, MH | 1 |
| Taghaddosinejad, F | 1 |
| Arefi, M | 1 |
| Sharifzadeh, M | 1 |
| Mojtahedzadeh, M | 1 |
| Nikfar, S | 1 |
| Baeeri, M | 1 |
| Rahimifard, M | 1 |
| Abdollahi, M | 1 |
| Gu, Y | 1 |
| Zheng, L | 1 |
| Zhang, Q | 1 |
| Liu, L | 1 |
| Meng, G | 1 |
| Yao, Z | 1 |
| Wu, H | 1 |
| Xia, Y | 1 |
| Bao, X | 1 |
| Shi, H | 1 |
| Wang, H | 1 |
| Xu, H | 1 |
| Sun, S | 1 |
| Wang, X | 1 |
| Zhou, M | 1 |
| Jia, Q | 1 |
| Song, K | 1 |
| Niu, K | 1 |
| Neves, JS | 1 |
| Leitão, L | 1 |
| Baeta Baptista, R | 1 |
| Bigotte Vieira, M | 1 |
| Magriço, R | 1 |
| Viegas Dias, C | 1 |
| Oliveira, A | 1 |
| Falcão-Pires, I | 1 |
| Lourenço, A | 1 |
| Carvalho, D | 1 |
| Leite-Moreira, A | 1 |
| Chattergoon, NN | 1 |
| Jorde, R | 1 |
| Schirmer, H | 1 |
| Wilsgaard, T | 1 |
| Joakimsen, RM | 1 |
| Mathiesen, EB | 1 |
| Njølstad, I | 1 |
| Løchen, ML | 1 |
| Figenschau, Y | 1 |
| Svartberg, J | 1 |
| Hutchinson, MS | 1 |
| Kjærgaard, M | 1 |
| Jørgensen, L | 1 |
| Grimnes, G | 1 |
| Roef, GL | 1 |
| Rietzschel, ER | 1 |
| Van Daele, CM | 1 |
| Taes, YE | 1 |
| De Buyzere, ML | 1 |
| Gillebert, TC | 1 |
| Kaufman, JM | 1 |
| Iglesias, P | 1 |
| Ridruejo, E | 1 |
| Muñoz, A | 1 |
| Prado, F | 1 |
| Macías, MC | 1 |
| Guerrero, MT | 1 |
| Tajada, P | 1 |
| García-Arévalo, C | 1 |
| Díez, JJ | 1 |
| Dudka, J | 1 |
| Mandziuk, S | 1 |
| Madej-Czerwonka, B | 1 |
| Sierocińska-Sawa, J | 1 |
| Walczyna, B | 1 |
| Korga, A | 1 |
| Cendrowska-Pinkosz, M | 1 |
| Burdan, F | 1 |
| Rhee, CM | 2 |
| Brent, GA | 1 |
| Kovesdy, CP | 1 |
| Soldin, OP | 1 |
| Nguyen, D | 1 |
| Budoff, MJ | 1 |
| Brunelli, SM | 1 |
| Kalantar-Zadeh, K | 1 |
| Faber, J | 1 |
| Selmer, C | 1 |
| Xu, G | 1 |
| Yan, Y | 1 |
| Fraczek, MM | 1 |
| Łacka, K | 1 |
| Chang, TI | 1 |
| Nam, JY | 1 |
| Shin, SK | 1 |
| Kang, EW | 1 |
| Wang, J | 1 |
| Zheng, X | 1 |
| Sun, M | 1 |
| Wang, Z | 1 |
| Fu, Q | 1 |
| Shi, Y | 1 |
| Cao, M | 1 |
| Zhu, Z | 1 |
| Meng, C | 1 |
| Mao, J | 1 |
| Yang, F | 1 |
| Huang, X | 1 |
| Zhou, H | 1 |
| Duan, Y | 1 |
| He, W | 1 |
| Zhang, M | 1 |
| Yang, T | 1 |
| Lee, YM | 1 |
| Ki, YJ | 1 |
| Choi, DH | 1 |
| Kim, BB | 1 |
| Shin, BC | 1 |
| Song, H | 1 |
| Kim, DM | 1 |
| Obradovic, M | 1 |
| Gluvic, Z | 1 |
| Sudar-Milovanovic, E | 1 |
| Panic, A | 1 |
| Trebaljevac, J | 1 |
| Bajic, V | 1 |
| Zarkovic, M | 1 |
| Isenovic, ER | 1 |
| Abbas, AM | 1 |
| Sakr, HF | 1 |
| Leese, GP | 1 |
| Soto-Pedre, E | 1 |
| Donnelly, LA | 1 |
| Salerno, M | 1 |
| Capalbo, D | 1 |
| Cerbone, M | 1 |
| De Luca, F | 1 |
| Pearce, SH | 1 |
| Razvi, S | 1 |
| Yadegarfar, ME | 1 |
| Martin-Ruiz, C | 1 |
| Kingston, A | 1 |
| Collerton, J | 1 |
| Visser, TJ | 1 |
| Kirkwood, TB | 1 |
| Jagger, C | 1 |
| Le, TN | 1 |
| Celi, FS | 1 |
| Wickham, EP | 1 |
| Merke, A | 1 |
| Merke, J | 1 |
| Silbernagel, G | 1 |
| März, W | 1 |
| Bonde, Y | 1 |
| Angelin, B | 2 |
| Kim, HJ | 1 |
| Bae, JC | 1 |
| Park, HK | 1 |
| Byun, DW | 1 |
| Suh, K | 1 |
| Yoo, MH | 1 |
| Jae Hwan, J | 1 |
| Kim, JH | 1 |
| Min, YK | 1 |
| Kim, SW | 1 |
| Chung, JH | 1 |
| Owen, PJ | 1 |
| Chatterjee, VK | 1 |
| John, R | 1 |
| Halsall, D | 1 |
| Lazarus, JH | 1 |
| Erem, C | 1 |
| Ucuncu, O | 1 |
| Yilmaz, M | 1 |
| Kocak, M | 1 |
| Nuhoglu, İ | 1 |
| Ersoz, HO | 1 |
| Klubo-Gwiezdzinska, J | 1 |
| Wartofsky, L | 2 |
| Ittermann, T | 1 |
| Haring, R | 1 |
| Sauer, S | 1 |
| Wallaschofski, H | 1 |
| Dörr, M | 1 |
| Nauck, M | 1 |
| Völzke, H | 1 |
| Gerdes, AM | 2 |
| Iervasi, G | 1 |
| Gu, LQ | 1 |
| Zhao, L | 1 |
| Zhu, W | 1 |
| Li, FY | 1 |
| Zhang, MJ | 1 |
| Liu, JM | 1 |
| Ning, G | 1 |
| Zhao, YJ | 1 |
| Yang, JW | 1 |
| Han, ST | 1 |
| Song, SH | 1 |
| Kim, MK | 1 |
| Kim, JS | 1 |
| Choi, SO | 1 |
| Han, BG | 1 |
| Danzi, S | 3 |
| Klein, I | 3 |
| Mittal, A | 1 |
| Poudel, B | 1 |
| Pandeya, DR | 1 |
| Gupta, SP | 1 |
| Sathian, B | 1 |
| Yadav, SK | 1 |
| Solá, E | 1 |
| Gómez-Balaguer, M | 1 |
| Morillas, C | 1 |
| Garzón, S | 1 |
| García, S | 1 |
| Morcillo, EJ | 1 |
| Hernández-Mijares, A | 1 |
| Tripepi, G | 1 |
| Zoccali, C | 1 |
| FOLKMAN, J | 1 |
| EDMUNDS, LH | 1 |
| TORO-GOYCO, E | 1 |
| RAMIREZ, EA | 1 |
| RIVERA, JV | 1 |
| RIVERA, E | 1 |
| Cantürk, Z | 1 |
| Cetinarslan, B | 1 |
| Tarkun, I | 1 |
| Cantürk, NZ | 1 |
| Ozden, M | 1 |
| Duman, C | 1 |
| Ametov, AS | 1 |
| Balashova, NV | 1 |
| Giliarevskiĭ, SR | 1 |
| Botella-Carretero, JI | 1 |
| Gómez-Bueno, M | 1 |
| Barrios, V | 1 |
| Caballero, C | 1 |
| García-Robles, R | 1 |
| Sancho, J | 1 |
| Escobar-Morreale, HF | 1 |
| Triantafillidis, JK | 1 |
| Georgakopoulos, D | 1 |
| Gikas, A | 1 |
| Merikas, E | 1 |
| Peros, G | 1 |
| Sofroniadou, K | 1 |
| Cheracakis, P | 1 |
| Sklavaina, M | 1 |
| Tzanidis, G | 1 |
| Konstantellou, E | 1 |
| Biondi, B | 2 |
| Palmieri, EA | 1 |
| Klain, M | 1 |
| Schlumberger, M | 1 |
| Filetti, S | 1 |
| Lombardi, G | 1 |
| Johansson, L | 1 |
| Rudling, M | 1 |
| Scanlan, TS | 1 |
| Lundåsen, T | 1 |
| Webb, P | 1 |
| Baxter, J | 1 |
| Parini, P | 1 |
| Ozcan, O | 1 |
| Cakir, E | 1 |
| Yaman, H | 1 |
| Akgul, EO | 1 |
| Erturk, K | 1 |
| Beyhan, Z | 1 |
| Bilgi, C | 1 |
| Erbil, MK | 1 |
| Dagre, AG | 1 |
| Lekakis, JP | 1 |
| Papaioannou, TG | 1 |
| Papamichael, CM | 1 |
| Koutras, DA | 1 |
| Stamatelopoulos, SF | 1 |
| Alevizaki, M | 1 |
| Roos, A | 1 |
| Bakker, SJ | 1 |
| Gans, RO | 1 |
| Wolffenbuttel, BH | 1 |
| Takasu, N | 1 |
| Duntas, LH | 1 |
| Carrero, JJ | 1 |
| Qureshi, AR | 1 |
| Axelsson, J | 1 |
| Yilmaz, MI | 1 |
| Rehnmark, S | 1 |
| Witt, MR | 1 |
| Bárány, P | 1 |
| Heimbürger, O | 1 |
| Suliman, ME | 1 |
| Alvestrand, A | 1 |
| Lindholm, B | 1 |
| Stenvinkel, P | 1 |
| Cooper, DS | 1 |
| Redetzke, RA | 1 |
| Said, S | 1 |
| Pottala, JV | 1 |
| de Escobar, GM | 1 |
| Kollmannsberger, A | 1 |
| Kugler, J | 1 |
| Schwarz, K | 1 |
| Scriba, PC | 1 |
| Seppel, T | 1 |
| Becker, A | 1 |
| Lippert, F | 1 |
| Schlaghecke, R | 1 |
| Nedrebø, BG | 1 |
| Ericsson, UB | 1 |
| Nygård, O | 1 |
| Refsum, H | 1 |
| Ueland, PM | 1 |
| Aakvaag, A | 1 |
| Aanderud, S | 1 |
| Lien, EA | 1 |
| Gruber, DM | 1 |
| Huber, JC | 1 |
| Al-Abadi, AC | 1 |
| Burger, A | 1 |
| Nicod, P | 1 |
| Suter, P | 1 |
| Vallotton, MB | 1 |
| Vagenakis, P | 1 |
| Braverman, L | 1 |
| Helenius, T | 1 |
| Liewendahl, K | 1 |
| Brun, R | 1 |
| Jenny, M | 1 |
| Junod, JP | 1 |
| Block, MB | 1 |
| Rubello, D | 1 |
| Busnardo, B | 1 |
| Girelli, ME | 1 |
| Piccolo, M | 1 |
| Aghini-Lombardi, F | 1 |
| Lenziardi, M | 1 |
| Martino, E | 1 |
| Pinchera, A | 1 |
| Casey, AE | 1 |
| Downey, EL | 1 |
| Copeland, H | 1 |
| Wilks, MN | 1 |
| Inada, M | 1 |
| Green, D | 1 |
| Smith, NJ | 1 |
20 reviews available for triiodothyronine and Cardiovascular Diseases
| Article | Year |
|---|---|
Effects of oral contraceptives on thyroid function and vice versa.
Topics: Blood Coagulation; Cardiovascular Diseases; Contraception; Contraceptives, Oral; Drug Interactions; | 2020 |
[Use of thyroid hormones in the treatment of cardiovascular diseases: literature review].
Topics: Animals; Cardiovascular Diseases; Humans; Myocardial Infarction; Thyroid Hormones; Thyroxine; Triiod | 2020 |
Thyroid hormone signaling and consequences for cardiac development.
Topics: Animals; Cardiovascular Diseases; Cell Proliferation; Female; Fetal Development; Fetal Heart; Heart; | 2019 |
Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients.
Topics: Animals; Cardiovascular Diseases; Comorbidity; Hormone Replacement Therapy; Humans; Hypothyroidism; | 2015 |
[Thyroid hormone and the cardiovascular system].
Topics: Cardiovascular Diseases; Humans; Mitosis; Myocytes, Cardiac; Thyroid Hormone Receptors alpha; Thyroi | 2014 |
Nitric Oxide as a Marker for Levo-Thyroxine Therapy in Subclinical Hypothyroid Patients.
Topics: Animals; Biomarkers; Cardiovascular Diseases; Humans; Hypothyroidism; Nitric Oxide; Risk Factors; Th | 2016 |
Subclinical hypothyroidism in childhood - current knowledge and open issues.
Topics: Anticonvulsants; Antiviral Agents; Asymptomatic Diseases; Atherosclerosis; Bone Diseases, Metabolic; | 2016 |
Thyroid replacement therapy and heart failure.
Topics: Animals; Cardiovascular Diseases; Diiodothyronines; Disease Models, Animal; Glomerular Filtration Ra | 2010 |
Thyroid hormone and the cardiovascular system.
Topics: Animals; Blood Vessels; Calcium-Transporting ATPases; Cardiovascular Diseases; Cardiovascular Physio | 2012 |
Thyroid hormone-regulated cardiac gene expression and cardiovascular disease.
Topics: Amiodarone; Animals; Cardiovascular Diseases; Cytokines; Gene Expression Regulation; Humans; Hypothy | 2002 |
[Syndrome of non-thyroid pathology in patients with cardiovascular diseases (review)].
Topics: Anti-Arrhythmia Agents; Cardiovascular Diseases; Euthyroid Sick Syndromes; Humans; Thyroxine; Triiod | 2003 |
Thyroid hormone and the cardiovascular system.
Topics: Blood Vessels; Calcium-Transporting ATPases; Cardiovascular Diseases; Cardiovascular Physiological P | 2004 |
Subclinical hyperthyroidism: clinical features and treatment options.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Cardiovascular Diseases; Female; Humans; Hyperthyroid | 2005 |
[Thyroid hormone and the cardiovascular system].
Topics: Animals; Biomarkers; Cardiovascular Diseases; Gene Expression Regulation; Heart Conduction System; H | 2006 |
Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence?
Topics: Adult; Aged; Aged, 80 and over; Blood Coagulation Disorders; Cardiovascular Diseases; Humans; Hyperc | 2007 |
The clinical significance of subclinical thyroid dysfunction.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Calcification, Physiologic; Cardiovascular Diseas | 2008 |
Conjugated estrogens--the natural SERMs.
Topics: 2-Methoxyestradiol; Anticarcinogenic Agents; Cardiovascular Diseases; Dihydrotestosterone; Equilin; | 1999 |
Subclinical thyrotoxicosis.
Topics: Cardiovascular Diseases; Diagnosis, Differential; Disease Progression; Humans; Hyperthyroidism; Oste | 2001 |
[Thyroxine binding protein, free thyroxine and triiodothyronine--interpretation of the test results].
Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Child; Diabetes Mellitus; Female; Humans; Infectio | 1973 |
Hemophilia. Current concepts in management.
Topics: Adrenal Cortex Hormones; Adult; Analgesics; Antifibrinolytic Agents; Blood Transfusion; Cardiovascul | 1972 |
2 trials available for triiodothyronine and Cardiovascular Diseases
| Article | Year |
|---|---|
Therapeutic effects of oral liothyronine on aluminum phosphide poisoning as an adjuvant therapy: A clinical trial.
Topics: Administration, Oral; Adult; Aluminum Compounds; Antidotes; Biomarkers; Blood Pressure; Cardiovascul | 2018 |
Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism.
Topics: Adult; Blood Pressure; Cardiovascular Diseases; Female; Fibrinolysis; Hemostasis; Humans; Hypothyroi | 2003 |
59 other studies available for triiodothyronine and Cardiovascular Diseases
| Article | Year |
|---|---|
Higher Free Triiodothyronine Is Associated With Higher HDL Particle Concentration and Smaller HDL Particle Size.
Topics: Cardiovascular Diseases; Cross-Sectional Studies; Humans; Particle Size; Sexually Transmitted Diseas | 2022 |
Editorial: The effects of circulating non-sex hormones in cardiovascular disease.
Topics: Cardiovascular Diseases; Humans; Thyroxine; Triiodothyronine | 2022 |
J-shaped association of free triiodothyronine to free thyroxine ratio with 5-year mortality among patients with chronic kidney disease: a prospective cohort study.
Topics: Cardiovascular Diseases; Humans; Nutrition Surveys; Prospective Studies; Renal Insufficiency, Chroni | 2023 |
Lower free triiodothyronine levels are associated with higher all-cause and cardiovascular mortality in people with diabetes-NHANES 2007-2012.
Topics: Cardiovascular Diseases; Cardiovascular System; Diabetes Mellitus; Humans; Nutrition Surveys; Retros | 2023 |
Thyroid function test variability and cardiovascular morbidity in hyperthyroidism.
Topics: Antithyroid Agents; Cardiovascular Diseases; Graves Disease; Humans; Hyperthyroidism; Male; Retrospe | 2023 |
Subclinical hypothyroidism: To treat or not to treat?
Topics: Aged; Asymptomatic Diseases; Autoantigens; Biomarkers; Cardiovascular Diseases; Diagnosis, Different | 2020 |
Thyroid function and risk of all-cause and cardiovascular mortality: a prospective population-based cohort study.
Topics: Adult; Aged; Cardiovascular Diseases; Cohort Studies; Female; Humans; Male; Middle Aged; Prospective | 2021 |
Role of Thyroid Hormone and Oxidant Stress in Cardiovascular Diseases.
Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Dyslipidemias; Heart | 2021 |
Low Free Triiodothyronine Level as a Predictor of Cardiovascular Events and All-Cause Mortality in Patients Undergoing Hemodialysis: The DREAM Cohort.
Topics: Aged; Cardiovascular Diseases; Cross-Sectional Studies; Female; Heart Disease Risk Factors; Humans; | 2021 |
Usefulness of FT3 to FT4 Ratio to Predict Mortality in Euthyroid Patients With Prior Cardiovascular Events Undergoing PCI: Five-Year Findings From a Large Single-Center Cohort Study.
Topics: Biomarkers; Cardiovascular Diseases; Female; Follow-Up Studies; Humans; Male; Middle Aged; Percutane | 2021 |
Association of triiodothyronine levels with left ventricular function, cardiovascular events, and mortality in hemodialysis patients.
Topics: Adult; Aged; Cardiovascular Diseases; Cohort Studies; Echocardiography; Euthyroid Sick Syndromes; Fe | 2017 |
Relationship between thyroid function and elevated blood pressure in euthyroid adults.
Topics: Adult; Blood Pressure Determination; Cardiovascular Diseases; China; Cross-Sectional Studies; Female | 2018 |
Lower free triiodothyronine levels within the reference range are associated with higher cardiovascular mortality: An analysis of the NHANES.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Cardiovascular Diseases; Cause of Death; Fem | 2019 |
The phosphodiesterase 8B gene rs4704397 is associated with thyroid function, risk of myocardial infarction, and body height: the Tromsø study.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Aged; Body Height; Cardiovascular Diseases; Diabetes Mel | 2014 |
Triiodothyronine and free thyroxine levels are differentially associated with metabolic profile and adiposity-related cardiovascular risk markers in euthyroid middle-aged subjects.
Topics: Adult; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Humans; Inter | 2014 |
Thyroid function tests and mortality in aged hospitalized patients: a 7-year prospective observational study.
Topics: Aged; Aged, 80 and over; Aging; Cardiovascular Diseases; Cross-Sectional Studies; Female; Follow-Up | 2013 |
Effect of iodothyronine hormone status on doxorubicin related cardiotoxicity.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Cardiovascular Diseases; Creatine Kinase | 2013 |
Cardiovascular disease and thyroid function.
Topics: Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Cardiovascular Diseases; Female; Heart; Heart F | 2014 |
The cardiovascular disease risks of nonthyroidal illness syndrome and inflammatory responses on patients with chronic kidney disease: from the association to clinical prognosis.
Topics: Adult; Aged; Cardiovascular Diseases; Echocardiography; Female; Humans; Hypertrophy, Left Ventricula | 2014 |
Low Triiodothyronine Syndrome and Long-Term Cardiovascular Outcome in Incident Peritoneal Dialysis Patients.
Topics: Adult; Aged; Cardiovascular Diseases; Female; Humans; Hypothyroidism; Incidence; Kaplan-Meier Estima | 2015 |
Low-T3 Syndrome in Peritoneal Dialysis: Metabolic Adaptation, Marker of Illness, or Mortality Mediator?
Topics: Cardiovascular Diseases; Female; Humans; Hypothyroidism; Male; Peritoneal Dialysis; Renal Insufficie | 2015 |
Low serum free thyroxine concentrations associate with increased arterial stiffness in euthyroid subjects: a population-based cross-sectional study.
Topics: Aged; Ankle Brachial Index; Autoantibodies; Autoantigens; Cardiovascular Diseases; China; Cross-Sect | 2015 |
Value of Low Triiodothyronine and Subclinical Myocardial Injury for Clinical Outcomes in Chest Pain.
Topics: Adult; Aged; Biomarkers; Cardiovascular Diseases; Chest Pain; Female; Humans; Kaplan-Meier Estimate; | 2015 |
Effect of magnesium sulfate and thyroxine on inflammatory markers in a rat model of hypothyroidism.
Topics: Animals; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Hypothyroidism; Inflammation; Inte | 2016 |
Liothyronine use in a 17 year observational population-based study - the tears study.
Topics: Antipsychotic Agents; Atrial Fibrillation; Cardiovascular Diseases; Cohort Studies; Fractures, Bone; | 2016 |
Serum Thyroid Function, Mortality and Disability in Advanced Old Age: The Newcastle 85+ Study.
Topics: Aged, 80 and over; Cardiovascular Diseases; Dextrothyroxine; Disabled Persons; England; Female; Huma | 2016 |
Thyrotropin Levels Are Associated with Cardiometabolic Risk Factors in Euthyroid Adolescents.
Topics: Adolescent; Biomarkers; Cardiovascular Diseases; Child; Cohort Studies; Cross-Sectional Studies; Dys | 2016 |
FREE THYROID HORMONES AND MORTALITY IN CAUCASIANS UNDERGOING ANGIOGRAPHY: THE LUDWIGSHAFEN RISK AND CARDIOVASCULAR HEALTH (LURIC) STUDY.
Topics: Aged; Aged, 80 and over; Angiography; Cardiovascular Diseases; Female; Follow-Up Studies; Germany; H | 2017 |
Metabolic Syndrome: One Speckled Stone Kills a Flock of Birds?
Topics: Animals; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Fatty Liver; Glucagon; Hormones; Humans | 2017 |
Association of triiodothyronine levels with future development of metabolic syndrome in euthyroid middle-aged subjects: a 6-year retrospective longitudinal study.
Topics: Adult; Aged; Cardiovascular Diseases; Cross-Sectional Studies; Female; Humans; Longitudinal Studies; | 2017 |
Augmentation index in resistance to thyroid hormone (RTH).
Topics: Adult; Blood Glucose; Cardiovascular Diseases; Case-Control Studies; Cholesterol, LDL; Cohort Studie | 2009 |
Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism.
Topics: Adult; Blood Pressure; Carboxypeptidase B2; Cardiovascular Diseases; Case-Control Studies; Down-Regu | 2009 |
Thyrotropin blood levels, subclinical hypothyroidism, and the elderly patient.
Topics: Activities of Daily Living; Aged; Biomarkers; Cardiovascular Diseases; Female; Humans; Hypothyroidis | 2009 |
Decreased serum TSH levels are not associated with mortality in the adult northeast German population.
Topics: Adult; Aged; Cardiovascular Diseases; Female; Follow-Up Studies; Germany; Humans; Male; Middle Aged; | 2010 |
Relationships between serum levels of thyroid hormones and serum concentrations of asymmetric dimethylarginine (ADMA) and N-terminal-pro-B-type natriuretic peptide (NT-proBNP) in patients with Graves' disease.
Topics: Adult; Arginine; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cross-Sectional Studies; Endot | 2011 |
Serum T3 level can predict cardiovascular events and all-cause mortality rates in CKD patients with proteinuria.
Topics: Biomarkers; Cardiovascular Diseases; Cause of Death; Disease Progression; Female; Follow-Up Studies; | 2012 |
Metabolic changes enhance the cardiovascular risk with differentiated thyroid carcinoma--a case control study from Manipal Teaching Hospital of Nepal.
Topics: Biomarkers; Cardiovascular Diseases; Case-Control Studies; Cell Differentiation; Female; Humans; Ins | 2012 |
Massive triiodothyronine intoxication: efficacy of hemoperfusion?
Topics: Adult; Cardiovascular Diseases; Central Nervous System Diseases; Critical Care; Female; Hemoperfusio | 2002 |
Low triiodothyronine and cardiovascular disease.
Topics: Biomarkers; Cardiovascular Diseases; Confounding Factors, Epidemiologic; Data Interpretation, Statis | 2003 |
Endocrine pacemaker for complete heart block.
Topics: Adrenal Medulla; Cardiovascular Diseases; Heart Block; Pacemaker, Artificial; Thyroid Gland; Triiodo | 1962 |
The binding of radioactive triiodothyronine by erythrocytes in myocardial infarction.
Topics: Anti-Arrhythmia Agents; Cardiovascular Diseases; Erythrocytes; Humans; Myocardial Infarction; Triiod | 1963 |
Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma.
Topics: Adult; Blood Pressure; Carcinoma, Papillary, Follicular; Cardiovascular Diseases; Cell Differentiati | 2004 |
Relation between Helicobacter pylori infection, thyroid hormone levels and cardiovascular risk factors on blood donors.
Topics: Adult; Age Factors; Autoantibodies; Blood Donors; Cardiovascular Diseases; Cholesterol; Educational | 2003 |
Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice.
Topics: Acetates; Analysis of Variance; Animals; Bile Acids and Salts; Cardiovascular Diseases; CD36 Antigen | 2005 |
The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism.
Topics: Adolescent; Adult; Aged; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Choleste | 2005 |
Arterial stiffness is increased in subjects with hypothyroidism.
Topics: Adult; Biomarkers; Blood Pressure; Cardiovascular Diseases; Female; Humans; Hypothyroidism; Male; Mi | 2005 |
Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects.
Topics: Adult; Aged; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Female; Homeostasis; Human | 2007 |
Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Epidemiologic Methods; Female; | 2007 |
Serum thyroid hormone levels may not accurately reflect thyroid tissue levels and cardiac function in mild hypothyroidism.
Topics: Animals; Arterioles; Atrophy; Cardiovascular Diseases; Coronary Vessels; Disease Models, Animal; Dos | 2008 |
[The thyreotoxic encephalopathy].
Topics: Adult; Atrial Fibrillation; Brain; Brain Diseases; Cardiovascular Diseases; Electroencephalography; | 1967 |
Serum sex hormone-binding globulin and osteocalcin in systemic nonthyroidal illness associated with low thyroid hormone concentrations.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Cardiovascular Diseases; Communicable Diseases; Female; | 1996 |
Plasma total homocysteine levels in hyperthyroid and hypothyroid patients.
Topics: Adult; Aged; Arteriosclerosis; Cardiovascular Diseases; Cholesterol; Creatinine; Female; Folic Acid; | 1998 |
Reduced active thyroid hormone levels in acute illness.
Topics: Acute Disease; Adult; Aged; Bronchitis; Cardiovascular Diseases; Child; Female; Gastroenteritis; Hum | 1976 |
Abnormal thyroid function tests in devere non-thyroidal illness: diagnostic and pathophysiologic aspects.
Topics: Adult; Aged; Cardiovascular Diseases; Fatty Acids, Nonesterified; Female; Gastrointestinal Diseases; | 1979 |
[Hyperthyroidism in older patients].
Topics: Aged; Cardiovascular Diseases; Diagnosis, Differential; Goiter, Nodular; Graves Disease; Humans; Hyp | 1978 |
Therapeutics: recent suggestions for the treatment of hypothyroidism and diabetes mellitus.
Topics: Cardiovascular Diseases; Diabetes Mellitus; Humans; Hypothyroidism; Phenformin; Sulfonylurea Compoun | 1975 |
Severe hyperthyroidism due to neoplastic TSH hypersecretion in an old man.
Topics: Bromocriptine; Cardiovascular Diseases; Humans; Hyperthyroidism; Male; Methimazole; Middle Aged; Pit | 1989 |
[Amiodarone and thyroid function].
Topics: Adult; Aged; Amiodarone; Cardiovascular Diseases; Drug Administration Schedule; Female; Humans; Hype | 1987 |
Lactic dehydrogenase, leucine aminopeptidase, alpha globulin, and azotemia in circulatory stress.
Topics: Alkaline Phosphatase; Alpha-Globulins; Aspartate Aminotransferases; Autoanalysis; Blood Urea Nitroge | 1974 |